Crows (especially American crows) are highly intelligent and have remarkable abilities to recognize individual human faces, remember negative experiences with specific people for years (up to 17 in some studies), and socially transmit that information to their offspring and other crows, even those who never directly experienced the original incident.
Researchers wore distinct masks while trapping and banding a small number of crows (a stressful but non-harmful experience for the birds). The crows quickly learned to associate that specific "dangerous" face with threat and responded by scolding, mobbing, and dive-bombing anyone wearing it.
Offspring and other crows picked this up through observation: young birds (fledglings born later) would join in or react independently after seeing their parents' alarm calls and behavior. This "knowledge" spread through the local crow population via social learning, turning a personal grudge into a community warning.
[Cornell, H. N., Marzluff, J. M., & Pecoraro, S. (2012).
Social learning spreads knowledge about dangerous humans among American crows.
Proceedings of the Royal Society B: Biological Sciences, 279(1728), 499–508.
DOI: 10.1098/rspb.2011.0957]
Scientists have discovered a promising new way to help the immune system detect and attack hidden cancer cells.
A first-in-class drug called GRWD5769 (an oral ERAP1 inhibitor) has shown encouraging early results, shrinking tumors in patients with six different types of advanced cancer: lung, liver, bladder, cervical, head and neck, and colorectal.
In a Phase 1/1b clinical trial (EMITT-1) involving 83 heavily pre-treated patients across multiple countries, tumors shrank in 26 participants. Of those, 15 experienced reductions of at least 30%. Many patients had already failed prior therapies, including immunotherapies.
The drug works by blocking the enzyme ERAP1, which cancers often use to “edit” their surface proteins and evade immune detection. By inhibiting ERAP1, GRWD5769 alters the tumor’s antigen presentation, effectively removing the cancer’s invisibility cloak and making the cells more visible to the immune system. It was tested in combination with the PD-1 inhibitor cemiplimab (Libtayo).
Particularly strong signals were seen in certain hard-to-treat cancers. For example, disease control for at least six months was achieved in 51% of colorectal cancer patients and 55% of lung cancer patients in the expansion cohorts.
While these early results are promising, experts emphasize this is still an early-phase study. Larger trials are needed to confirm efficacy, durability of response, and impact on long-term survival.
If successful, this approach could expand the number of patients who benefit from immunotherapy — which currently works in only about one-third of cases.
[Grey Wolf Therapeutics. “EMITT-1: Clinical and pharmacodynamic activity with the oral ERAP1 inhibitor GRWD5769 and cemiplimab in 6 completed phase 1b expansion cohorts in solid tumors...” Presented at ASCO Annual Meeting, 2026]
The Academy has issued a statement after Teyana Taylor was shoved at the #Oscars:
"We were extremely upset to learn about the experience endured by Teyana Taylor at the end of the Oscars ceremony last night. We have worked with Teyana over the last several months during awards season, and she has been nothing short of remarkable, supportive, kind, and all about community.
Though the incident was with our outside security firm SIS, the experience of every single guest is our responsibility. We have made it clear to them that this behavior is not acceptable.
We want to thank Teyana for showing remarkable grace, and we are taking the appropriate measures to ensure this does not happen again."
https://t.co/ID0ND7vYf0
Can you take the gift and accept my invitation? Only 2 steps, take your free gifts from top-notch activity TEMU Free Gifts and help me get mine!
https://t.co/5STsCZxWZA
Notice what happens...
A white girl is bullying a smaller Black girl.
Kids laugh, the teacher does nothing.
A Black girl jumps in to defend her friend and starts beating the brakes off of the bully.
The teacher jumps in to stop it.
I wonder whyTE.